|
NZ523656A
(en)
|
2000-08-31 |
2004-11-26 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
MXPA06007820A
(es)
|
2004-01-09 |
2006-09-01 |
Novartis Ag |
Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina como inhibidores de igf-ir.
|
|
US7405220B2
(en)
*
|
2004-06-09 |
2008-07-29 |
Hoffmann-La Roche Inc. |
Pyrazolopyrimidines
|
|
US8362031B2
(en)
|
2004-08-20 |
2013-01-29 |
University Of Kansas |
Lonidamine analogues and treatment of polycystic kidney disease
|
|
ES2347172T3
(es)
|
2005-02-16 |
2010-10-26 |
Astrazeneca Ab |
Compuestos quimicos.
|
|
FR2889526B1
(fr)
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
EP1926734A1
(en)
*
|
2005-08-22 |
2008-06-04 |
Amgen Inc. |
Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
|
|
WO2008117050A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer
|
|
JP2010524911A
(ja)
*
|
2007-04-18 |
2010-07-22 |
アストラゼネカ アクチボラグ |
５−アミノピラゾール−３−イル−３Ｈ−イミダゾ［４，５−ｂ］ピリジン誘導体と癌の治療のためのその使用
|
|
CN101970440A
(zh)
*
|
2007-11-28 |
2011-02-09 |
先灵公司 |
作为蛋白激酶抑制剂的2-氟吡唑并[1，5-a]嘧啶类
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
KR20110049217A
(ko)
|
2009-11-04 |
2011-05-12 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
|
EA030141B1
(ru)
|
2009-12-31 |
2018-06-29 |
Хатчисон Медифарма Лимитед |
Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
|
|
JO3145B1
(ar)
|
2010-11-08 |
2017-09-20 |
Lilly Co Eli |
مركبات مفيدة لتثبيط chk1
|
|
KR20120063283A
(ko)
|
2010-12-07 |
2012-06-15 |
제일약품주식회사 |
신규한 피라졸로 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
|
|
WO2013026021A2
(en)
|
2011-08-18 |
2013-02-21 |
Buck Institute For Research On Aging |
Trka as a target for inhibiting app cleavage and/or progression of alzheimer's disease
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
PT2994465T
(pt)
|
2013-05-10 |
2018-10-25 |
Karus Therapeutics Ltd |
Novos inibidores de histona desacetilase
|
|
RS58361B1
(sr)
|
2013-07-31 |
2019-03-29 |
Merck Patent Gmbh |
Piridini, pirimidini i pirazini, kao inhibitori btk i njihova upotreba
|
|
WO2016057322A1
(en)
|
2014-10-08 |
2016-04-14 |
Salk Institute For Biological Studies |
Ppar agonists and methods of use thereof
|
|
SI3302448T1
(sl)
|
2015-06-04 |
2024-03-29 |
Aurigene Oncology Limited |
Substituirani heterociklični derivati kot inhibitorji cdk
|
|
EP3548034A4
(en)
|
2016-12-05 |
2020-07-08 |
Microbiotix, Inc. |
BROAD SPECTRUM INHIBITORS OF FILOVIRUS
|
|
US12138263B2
(en)
|
2018-03-21 |
2024-11-12 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof
|
|
GB201808093D0
(en)
|
2018-05-18 |
2018-07-04 |
Enterprise Therapeutics Ltd |
Compounds
|
|
WO2020108516A1
(zh)
|
2018-11-27 |
2020-06-04 |
江苏豪森药业集团有限公司 |
含氮杂芳类衍生物调节剂、其制备方法和应用
|
|
WO2020108613A1
(zh)
*
|
2018-11-30 |
2020-06-04 |
江苏豪森药业集团有限公司 |
杂芳类衍生物调节剂、其制备方法和应用
|
|
IL284589B2
(en)
|
2019-01-31 |
2025-10-01 |
Pfizer |
3–Carbonylamino–5–cyclopentyl–h1–pyrazole compounds with cdk2 inhibitory activity
|
|
PH12021551976A1
(en)
|
2019-02-15 |
2022-07-04 |
Incyte Corp |
Cyclin-dependent kinase 2 biomarkers and uses thereof
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
EP3990443A1
(en)
|
2019-06-28 |
2022-05-04 |
GB002, Inc. |
Heterocyclic kinase inhibitors and products and uses thereof
|
|
US11851426B2
(en)
|
2019-10-11 |
2023-12-26 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
US11634424B2
(en)
|
2019-11-29 |
2023-04-25 |
Medshine Discovery Inc. |
Diazaindole derivative and use thereof as CHK1 inhibitor
|
|
CN113135896B
(zh)
|
2020-01-18 |
2024-12-06 |
正大天晴药业集团股份有限公司 |
作为ret抑制剂的甲基吡唑类衍生物
|
|
CN114057733A
(zh)
|
2020-08-07 |
2022-02-18 |
海思科医药集团股份有限公司 |
一种并环杂环衍生物及其在医药上的应用
|
|
US20230348475A1
(en)
|
2020-09-17 |
2023-11-02 |
The Translational Genomics Research Institute |
Imidazopyridazine and imidazopyrazine compounds as inhibitors of cdk7
|
|
WO2022174031A1
(en)
|
2021-02-12 |
2022-08-18 |
Relay Therapeutics, Inc. |
Cdk inhibitors and methods of use thereof
|
|
WO2022184130A1
(zh)
|
2021-03-03 |
2022-09-09 |
成都先导药物开发股份有限公司 |
一种nuak抑制剂及其用途
|
|
KR20240005751A
(ko)
|
2021-04-12 |
2024-01-12 |
에이2에이 파마수티칼스, 잉크. |
암 치료를 위한 조성물 및 방법
|
|
WO2022245776A1
(en)
|
2021-05-20 |
2022-11-24 |
Saint John's Cancer Institute |
Anti-cdk inhibitors for cancer treatment
|
|
MX2023015245A
(es)
|
2021-06-16 |
2024-01-19 |
Blueprint Medicines Corp |
Pirimidinil-pirazoles sustituidos como inhibidores de cdk2.
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
US11932648B2
(en)
|
2021-06-28 |
2024-03-19 |
Blueprint Medicines Corporation |
CDK2 inhibitors
|
|
WO2023092088A1
(en)
|
2021-11-19 |
2023-05-25 |
Blueprint Medicines Corporation |
Cdk2 inhibitors and methods of making and using same
|
|
IL317242A
(en)
|
2022-06-20 |
2025-01-01 |
Incyclix Bio Llc |
Cyclin-dependent kinase 2 inhibitors for medical treatment
|
|
CN117717565A
(zh)
|
2022-09-16 |
2024-03-19 |
北京悦康科创医药科技股份有限公司 |
反义寡核苷酸在制备治疗食管癌药物中的应用
|
|
WO2024148089A1
(en)
|
2023-01-04 |
2024-07-11 |
Blueprint Medicines Corporation |
Cdk2 inhibitors
|
|
JP2026501701A
(ja)
|
2023-01-04 |
2026-01-16 |
ブループリント メディシンズ コーポレイション |
Ｃｄｋ２阻害剤の固体形態
|
|
EP4646416A1
(en)
|
2023-01-04 |
2025-11-12 |
Blueprint Medicines Corporation |
Cdk2 inhibitors
|
|
CN120813586A
(zh)
|
2023-01-04 |
2025-10-17 |
缆图药品公司 |
Cdk2抑制剂
|
|
CN121311229A
(zh)
|
2023-02-10 |
2026-01-09 |
缆图药品公司 |
用于治疗癌症的cdk2抑制剂blu-222
|
|
KR20260010389A
(ko)
|
2023-04-14 |
2026-01-20 |
블루프린트 메디신즈 코포레이션 |
Cdk2 억제제
|